The efficacy of immunotherapy against triple-negative breast cancer (TNBC) heavily relies on intratumoral infiltration of cytotoxic T lymphocytes (CTLs). Although neoadjuvant chemotherapy together ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback